Directory
>
Paul Ashton
Paul Ashton
President and CEO | EyePoint Pharmaceuticals
Watertown, Massachusetts, United States
Paul Ashton
Summary
Paul Ashton is a seasoned biopharmaceutical executive with over 15 years of experience, currently serving as President and CEO of Inflammasome Therapeutics, Ltd. His leadership has been pivotal in developing sustained-release products that are among the few approved by the FDA for back-of-the-eye diseases. With a robust background in biotechnology and drug delivery, Paul has successfully raised significant funding and established strategic collaborations worth over $130 million. He is recognized for his ability to adapt strategies in response to market dynamics, demonstrating resilience during corporate restructuring. An internationally acknowledged scientist with over 200 publications and 120 patents, Paul has cultivated strong relationships with the FDA and Wall Street, enhancing his company's financial stability. His team-building skills are reflected in an impressive average employee tenure of over eight years, showcasing his commitment to fostering a collaborative work environment.
Paul Ashton
Work Experience
President and CEO at
Inflammasome Therapeutics
January 2017 - Present
President, Chief Executive Officer and a Director at
EyePoint Pharmaceuticals
January 2008 - Present
Managing Director (CEO) 2008, Director of Strategy 2006-2007, Director at
Psivida
January 2006 - January 2008
Company Founder, President and CEO 1996-2005; Vice President, Head of R&D 1992-1995 at
Control Delivery Systems, Inc.
January 1992 - January 2005
Assistant Professor Ophthalmology at
New England Eye Center
January 1995 - January 2000
Assistant Professor, Joint Appointments in Ophthalmology, Neurosurgery and Pharmacology at
University of Kentucky
January 1988 - January 1994
Research Scientist (pre-Ph.D) at
ROCHE LEON HOLDINGS
January 1983 - January 1984
Paul Ashton
Education
University of Southern California
January 1987 - January 1988
University of Wales, Cardiff, Doctor Of Philosophy (Ph.D.)
January 1984 - January 1987
Durham University, Bachelor’s Degree
January 1979 - January 1982
Frequently Asked Questions about Paul Ashton
What is Paul Ashton email address?
Paul Ashton's primary email address is *******@eyepointpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Paul Ashton work for?
Paul Ashton is a President and CEO at EyePoint Pharmaceuticals, a company specializing in Commercial physical research.
Where Paul Ashton graduated from?
Paul Ashton holds a degree in Post Doctoral Fellowship from University of Southern California.
How can I directly contact Paul Ashton?
To contact Paul Ashton directly, you can use the email address *******@eyepointpharma.com. Complete contact information is available upon registration with Muraena.
Who is Paul Ashton?
Paul Ashton is a seasoned biopharmaceutical executive with over 15 years of experience, currently serving as President and CEO of Inflammasome Therapeutics, Ltd. His leadership has been pivotal in developing sustained-release products that are among the few approved by the FDA for back-of-the-eye diseases. With a robust background in biotechnology and drug delivery, Paul has successfully raised significant funding and established strategic collaborations worth over $130 million. He is recognized for his ability to adapt strategies in response to market dynamics, demonstrating resilience during corporate restructuring. An internationally acknowledged scientist with over 200 publications and 120 patents, Paul has cultivated strong relationships with the FDA and Wall Street, enhancing his company's financial stability. His team-building skills are reflected in an impressive average employee tenure of over eight years, showcasing his commitment to fostering a collaborative work environment.
Paul`s contact details
*******@eyepointpharma.com
***********@att.net
Colleagues
Senior Vice President and Chief Technology Officer
Chief Legal Officer & Company Secretary
Chief Business Officer
VP, Chief of Staff
Vice President, Clinical Development -Ophthalmology
Vice President, Clinical Operations
Vice President Of Quality
VP, Market Access Strategy, Reimbursement and Government Affairs
Vice President, Intellectual Property
Member